129 related articles for article (PubMed ID: 38679036)
1. Carbapenem use in extended-spectrum cephalosporin-resistant Enterobacterales infections in US hospitals and influence of IDSA guidance: a retrospective cohort study.
Walker MK; Diao G; Warner S; Babiker A; Neupane M; Strich JR; Yek C; Kadri SS;
Lancet Infect Dis; 2024 Apr; ():. PubMed ID: 38679036
[TBL] [Abstract][Full Text] [Related]
2. Needs assessment for novel Gram-negative antibiotics in US hospitals: a retrospective cohort study.
Strich JR; Warner S; Lai YL; Demirkale CY; Powers JH; Danner RL; Kadri SS
Lancet Infect Dis; 2020 Oct; 20(10):1172-1181. PubMed ID: 32505231
[TBL] [Abstract][Full Text] [Related]
3. Infectious Diseases Society of America 2022 Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa).
Tamma PD; Aitken SL; Bonomo RA; Mathers AJ; van Duin D; Clancy CJ
Clin Infect Dis; 2022 Aug; 75(2):187-212. PubMed ID: 35439291
[TBL] [Abstract][Full Text] [Related]
4. Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa).
Tamma PD; Aitken SL; Bonomo RA; Mathers AJ; van Duin D; Clancy CJ
Clin Infect Dis; 2021 Apr; 72(7):1109-1116. PubMed ID: 33830222
[TBL] [Abstract][Full Text] [Related]
5. Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa).
Tamma PD; Aitken SL; Bonomo RA; Mathers AJ; van Duin D; Clancy CJ
Clin Infect Dis; 2021 Apr; 72(7):e169-e183. PubMed ID: 33106864
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of empiric carbapenem versus non-carbapenem therapy for extended-spectrum β-lactamase producing Enterobacterales infections in non-intensive care unit patients: a real-world investigation in a hospital with high-prevalence of extended-spectrum β-lactamase producing Enterobacterales.
Kang AY; Elkomos M; Pham D; Guerrero M; Kupferwasser D; Miller LG
Antimicrob Steward Healthc Epidemiol; 2024; 4(1):e100. PubMed ID: 38836043
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of carbapenem vs non carbapenem β-lactam therapy as empiric antimicrobial therapy in patients with extended-spectrum β-lactamase-producing Enterobacterales urinary septic shock: a propensity-weighted multicenter cohort study.
Cariou E; Griffier R; Orieux A; Silva S; Faguer S; Seguin T; Nseir S; Canet E; Desclaux A; Souweine B; Klouche K; Guisset O; Pillot J; Picard W; Saghi T; Delobel P; Gruson D; Prevel R; Boyer A
Ann Intensive Care; 2023 Mar; 13(1):22. PubMed ID: 36959425
[TBL] [Abstract][Full Text] [Related]
8. Infectious Diseases Society of America Guidance on the Treatment of AmpC β-Lactamase-Producing Enterobacterales, Carbapenem-Resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia Infections.
Tamma PD; Aitken SL; Bonomo RA; Mathers AJ; van Duin D; Clancy CJ
Clin Infect Dis; 2022 Jul; 74(12):2089-2114. PubMed ID: 34864936
[TBL] [Abstract][Full Text] [Related]
9. Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in-vitro susceptibilities: a retrospective cohort analysis of prevalence, predictors, and mortality risk in US hospitals.
Kadri SS; Lai YL; Warner S; Strich JR; Babiker A; Ricotta EE; Demirkale CY; Dekker JP; Palmore TN; Rhee C; Klompas M; Hooper DC; Powers JH; Srinivasan A; Danner RL; Adjemian J;
Lancet Infect Dis; 2021 Feb; 21(2):241-251. PubMed ID: 32916100
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of β-lactam/β-lactamase inhibitors to treat extended-spectrum beta-lactamase-producing Enterobacterales bacteremia secondary to urinary tract infection in kidney transplant recipients (INCREMENT-SOT Project).
Pierrotti LC; Pérez-Nadales E; Fernández-Ruiz M; Gutiérrez-Gutiérrez B; Tan BH; Carratalà J; Oriol I; Paul M; Cohen-Sinai N; López-Medrano F; San-Juan R; Montejo M; Freire MP; Cordero E; David MD; Merino E; Mehta Steinke S; Grossi PA; Cano Á; Seminari EM; Valerio M; Gunseren F; Rana M; Mularoni A; Martín-Dávila P; van Delden C; Hamiyet Demirkaya M; Koçak Tufan Z; Loeches B; Iyer RN; Soldani F; Eriksson BM; Pilmis B; Rizzi M; Coussement J; Clemente WT; Roilides E; Pascual Á; Martínez-Martínez L; Rodríguez-Baño J; Torre-Cisneros J; Aguado JM;
Transpl Infect Dis; 2021 Jun; 23(3):e13520. PubMed ID: 33222379
[TBL] [Abstract][Full Text] [Related]
11. Is Ceftazidime/Avibactam an Option for Serious Infections Due to Extended-Spectrum-β-Lactamase- and AmpC-Producing
Isler B; Ezure Y; Romero JLG; Harris P; Stewart AG; Paterson DL
Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33046493
[TBL] [Abstract][Full Text] [Related]
12. Thirty-Day Mortality Rates in Patients with Extended-Spectrum β-Lactamase-Producing
Park JJ; Jung EJ; Kim JY; Seo YB; Lee J; Jung Y
Antimicrob Agents Chemother; 2022 Jul; 66(7):e0028722. PubMed ID: 35708330
[TBL] [Abstract][Full Text] [Related]
13. European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine).
Paul M; Carrara E; Retamar P; Tängdén T; Bitterman R; Bonomo RA; de Waele J; Daikos GL; Akova M; Harbarth S; Pulcini C; Garnacho-Montero J; Seme K; Tumbarello M; Lindemann PC; Gandra S; Yu Y; Bassetti M; Mouton JW; Tacconelli E; Rodríguez-Baño J
Clin Microbiol Infect; 2022 Apr; 28(4):521-547. PubMed ID: 34923128
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Noncarbapenem β-Lactams Compared to Carbapenems for Extended-Spectrum β-Lactamase-Producing Enterobacterales Urinary Tract Infections.
Anderson DT; Albrecht B; Jones KA; Jacob JT; Sexton ME; Wiley Z; Dube WC; Lee B; Suchindran S
Open Forum Infect Dis; 2022 Mar; 9(3):ofac034. PubMed ID: 35174254
[TBL] [Abstract][Full Text] [Related]
15. Non-intravenous carbapenem-sparing antibiotics for definitive treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum β-lactamase (ESBL) or AmpC β-lactamase: A propensity score study.
Meije Y; Pigrau C; Fernández-Hidalgo N; Clemente M; Ortega L; Sanz X; Loureiro-Amigo J; Sierra M; Ayestarán A; Morales-Cartagena A; Ribera A; Duarte A; Abelenda G; Rodríguez-Baño J; Martínez-Montauti J
Int J Antimicrob Agents; 2019 Aug; 54(2):189-196. PubMed ID: 31075401
[TBL] [Abstract][Full Text] [Related]
16. Controversies over the management of infections caused by Amp-C- and ESBL-producing Enterobacterales : what questions remain for future studies?
Burillo A; Bouza E
Curr Opin Infect Dis; 2022 Dec; 35(6):575-582. PubMed ID: 35942862
[TBL] [Abstract][Full Text] [Related]
17. Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections.
Tamma PD; Aitken SL; Bonomo RA; Mathers AJ; van Duin D; Clancy CJ
Clin Infect Dis; 2023 Jul; ():. PubMed ID: 37463564
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of third-generation cephalosporins or piperacillin compared with cefepime or carbapenems for severe infections caused by wild-type AmpC β-lactamase-producing Enterobacterales: A multi-centre retrospective propensity-weighted study.
Maillard A; Delory T; Bernier J; Villa A; Chaibi K; Escaut L; Contejean A; Bercot B; Robert J; El Alaoui F; Tankovic J; Poupet H; Cuzon G; Lafaurie M; Surgers L; Joseph A; Paccoud O; Molina JM; Bleibtreu A;
Int J Antimicrob Agents; 2023 Jul; 62(1):106809. PubMed ID: 37028731
[TBL] [Abstract][Full Text] [Related]
19. Risk Factors for Carbapenem-Resistant
Rebold N; Lagnf AM; Alosaimy S; Holger DJ; Witucki P; Mannino A; Dierker M; Lucas K; Kunz Coyne AJ; El Ghali A; Caniff KE; Veve MP; Rybak MJ
Microbiol Spectr; 2023 Feb; 11(1):e0264722. PubMed ID: 36622246
[TBL] [Abstract][Full Text] [Related]
20. Extended-spectrum β-lactamase-producing and carbapenem-resistant Enterobacterales bloodstream infection after solid organ transplantation: Recent trends in epidemiology and therapeutic approaches.
Pérez-Nadales E; Fernández-Ruiz M; Gutiérrez-Gutiérrez B; Pascual Á; Rodríguez-Baño J; Martínez-Martínez L; Aguado JM; Torre-Cisneros J
Transpl Infect Dis; 2022 Aug; 24(4):e13881. PubMed ID: 35691028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
